Your prediction
Pros and Cons of Nymox Pharmaceutical Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nymox Pharmaceutical Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nymox Pharmaceutical Corp. | - | - | - | - | - | - | - |
| Enwave Corporation | -3.030% | -1.840% | 7.383% | 5.960% | -32.203% | -48.387% | -83.229% |
| Aurinia Pharmaceuticals Inc. | 2.750% | 0.073% | 8.949% | 109.126% | 1.225% | 33.939% | 27.489% |
| Spectral Medical Inc | -5.650% | -7.222% | 4.375% | 86.384% | 5.031% | 346.524% | 133.240% |
Comments
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat